Wednesday, February, 20, 2019 11:54:34

Category: Health

ZappRx and Teva Respiratory to enhance specialty medication delivery

ZappRx Inc., a healthcare tech company headquartered in Boston, and Teva Respiratory LLC, a US-based pharmaceutical company, have reportedly signed a collaboration deal to improve the delivery of specialty respiratory medication. Reportedly, the joint project is likely to render an efficient approach towards prescribing and …

argenx & Halozyme ink global collaboration & license agreement

Antibody therapeutic developer argenx and Halozyme Therapeutics, Inc. have reportedly announced a collaboration and license agreement that would enable the former to utilize Halozyme’s ENHANZE® drug delivery technology. Sources claim that argenx would be liable to use ENHANZE to generate subcutaneous product formulations for argenx’s …

FDA panel split over Lexicon-Sanofi diabetes drug Sotagliflozin

Not all 1.3 million American adults with type-1 diabetes will be eligible to receive Sotagliflozin. The U.S. Food and Drug Administration (FDA) advisory panel, was reportedly divided over whether to recommend the approval for a type-1 diabetes treatment developed by biopharmaceutical firms – Lexicon Pharmaceuticals …